[3] ZHAO N， HOU P， LV J， et al. The level of galactose-deficient IgA1 in the sera of patients with IgA nephropathy is associated with disease progression[J]. Kidney Int，2012，82(7)：790-796.
[4] XIE J， KIRYLUK K， WANG W， et al. Predicting progression of IgA nephropathy：new clinical progression risk score[J]. PLoS One， 2012，7(6)：e38904.
[5] DORVAL G， GRIBOUVAL O， MARTINEZ-BARQUERO V， et al. Clinical and genetic heterogeneity in familial steroid-sensitive nephrotic syndrome[J]. Pediatr Nephrol，2018，33(3)：473-483.
[6] LOMAX-BROWNE H J， VISCONTI A， Pusey C D， et al. IgA1 glycosylation is heritable in healthy twins[J]. J Am Soc Nephrol， 2017，28(1)：64-68.
[7] ZHANG Y M， ZHOU X J， ZHANG H. What genetics tells us about the pathogenesis of IgA nephropathy：the role of immune factors and infection[J]. Kidney Int Rep，2017，2(3)：318-331.
[8] AMBRUZS J M， WALKER P D， LARSEN C P. The histopathologic spectrum of kidney biopsies in patients with inflammatory bowel disease[J]. Clin J Am Soc Nephrol，2014，9(2)：265-270.
[9] COPPO R. The gut-kidney axis in IgA nephropathy：role of microbiota and diet on genetic predisposition[J]. Pediatr Nephrol， 2018，33(1)：53-61.
[10] ROLLINO C， VISCHINI G， COPPO R. IgA nephropathy and infections[J]. J Nephrol，2016，29(4)：463-468.
[11] GESUALDO L， LAMM M E， EMANCIPATOR S N. Defective oral tolerance promotes nephritogenesis in experimental IgA nephropathy induced by oral immunization[J]. J Immunol，1990，145(11)：3684-3691., http://www.100md.com(高向峰 饶向荣 李深 成庭柱 方吕贵 王秀娟)